JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
AVMA news
Catalyzing the field of canine comparative oncology, benefiting researchers far and wide
The Comparative Oncology Program at the National Institutes of Health has transformed canine comparative oncology since the program’s founding 20…
JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
AVMA news
Cultivating research on cancer in dogs, from clinical trials down to the molecular level
The Comparative Oncology Program at the National Institutes of Health, which promotes the study of cancer in dogs, manages the Comparative Oncology…
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
JAVMA news
Exploring a role for titers in rabies vaccination
Most states and many municipalities have laws requiring rabies vaccination for dogs and often cats, and these laws do not allow titer testing